Delivery Order HT942523D0011-HT942523F0306
- Not listed
- The Defense Health Agency awarded a $1,665,253.80 firm-fixed-price purchase order to Eitr Biologics, Inc. for novel cell sorting services. The contract is for sorting peripheral blood mononuclear cells from Venezuelan Equine Encephalitis Virus (VEEV) survivors to discover and produce monoclonal antibodies for in-vitro and in-vivo assessment against the virus. This award is not set aside. Eitr Biologics is a for-profit biotechnology company that specializes in developing innovative medical...
- This is a $315,662,883.70 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Eitr Biologics, Inc. to develop a multimodal antibody platform to extend the window of immunotherapeutic intervention against viral infections. The contract has a performance period through September 2030 and is not a set-aside. Eitr Biologics is a for-profit biotechnology company specializing in antibody-based platforms and antibody discovery...
- This is a $3,044,549.00 fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for biomedical research and development work, with a period of performance ending on March 31, 2010. No set-aside designations were used. Resilience Government Services, a technology-focused biomanufacturing company, has...
- <p>This is a $148,402.94 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Sanaria, Inc. under the Small Business Innovation Research (SBIR) Phase II program. The contract is for "Delivery System for Cryopreserved Eukaryotic Cell Vaccines" research and development work, with a completion date of January 10, 2019. The contract was set aside for small businesses.</p>
- This federal contract award was made by the Defense Health Agency (DHA) to Erivan Bio, LLC, a for-profit limited liability company, for a Small Business Technology Transfer (STTR) Phase I research project titled "Novel Scalable Loading of Antibiotics in Exosomes for Bacterial Wound Infection Prevention". The contract has a firm fixed price of $249,981.86 and a completion date of September 22, 2024. This STTR Phase I award supports research and development to develop a novel approach...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $99,299 cost-plus-fixed-fee delivery order was placed under the Therapeutics Against Infectious Diseases Phase 1 IDIQ contract, which funds Phase I clinical trials for therapeutic products targeting infectious diseases. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General Dynamics...
- This is a firm-fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Elusys Therapeutics Inc., a self-certified small disadvantaged business. The contract, valued at $24,501,100.00, is for "ANTHIM LETTER CONTRACT" and "FOR OTHER FUNCTIONS" services in the area of biomedical research and development. The contract has no set-aside designation and the period of...
- This is a $1,140,081.00 Small Business Innovation Research (STTR) Phase II contract awarded by the Defense Threat Reduction Agency to Biological Mimetics, Inc., a biotechnology company that combines biology and engineering to identify and prevent global infections. The contract is for research and development services related to infectious diseases, vaccines, diagnostics, and therapeutics. Biological Mimetics has previously received grants and contracts from federal agencies like the National...
- <p>This is a $149,500.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Nanomedical Diagnostics, Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES." The contract was awarded on October 24, 2016 with a final completion date of July 23, 2017.</p>
- This is a definitive contract awarded by the Department of the Army's Joint PEO Chemical and Biological Defense, a defense agency, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $366,290,602.35 cost-plus-fixed-fee contract is for the Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) Capability, with a period of performance through October 31, 2023. As a prime contractor, Resilience has provided a range of goods and services related...
- HT942523D0011Indefinite Delivery Contract
- HT942523D0011-HT942523F0306Delivery Order
This is a $750,000.00 firm fixed price delivery order awarded by the Defense Health Agency (DHA) to Eitr Biologics, Inc. for the development of novel nanotherapeutic approaches for the treatment of pneumonic plague. The order is part of a larger $4.39 million Indefinite Delivery Vehicle (IDV) contract between Eitr Biologics and DHA to advance the research and development of nanotherapeutics to combat biological threats. The work will be performed in San Diego, California and involves assessing potential therapies through in vitro and in vivo assays. Eitr Biologics is a for-profit biotechnology company specializing in the development of innovative medical countermeasures against viral infections and other biological threats. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $750.0k | 8/25/23 |